Salivary Gland Cancer Model for Survival +/- Postoperative Radiotherapy (PORT)
Predicts overall survival with and without postoperative radiotherapy (PORT) for resected major salivary gland cancers.
This calculator has not been externally validated. Use with caution.
Advice
- Use survival estimates in conjunction with clinical guidelines and specialist expertise to support personalized adjuvant therapy decisions.
- Despite the lack of randomized clinical trials, consider PORT for those with the following high-risk features:
- Advanced primary T stage (T3–4).
- Intermediate or high tumor grade.
- Adenoid cystic histology.
- Close or positive surgical margins.
- Perineural invasion.
- Lymphatic or vascular invasion.
- Lymph node metastases.